Global Generic Drugs Market Research Report 2023(Status and Outlook)
Report Overview
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The Global Generic Drugs Market Size was estimated at USD 313470 million in 2022 and is projected to reach USD 547766.14 million by 2029, exhibiting a CAGR of 8.30% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Generic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Generic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Generic Drugs market in any manner.
Global Generic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Market Segmentation (by Type)
Prescription
Non-Prescription Drugs
Market Segmentation (by Application)
Narrow-Body Aircraft
Wide-Body Aircraft
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Generic Drugs Market
Overview of the regional outlook of the Generic Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Generic Drugs
- 1.2 Key Market Segments
- 1.2.1 Generic Drugs Segment by Type
- 1.2.2 Generic Drugs Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Generic Drugs Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Generic Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Generic Drugs Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Generic Drugs Market Competitive Landscape
- 3.1 Global Generic Drugs Sales by Manufacturers (2018-2023)
- 3.2 Global Generic Drugs Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Generic Drugs Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Generic Drugs Sales Sites, Area Served, Product Type
- 3.6 Generic Drugs Market Competitive Situation and Trends
- 3.6.1 Generic Drugs Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Generic Drugs Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Generic Drugs Industry Chain Analysis
- 4.1 Generic Drugs Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Generic Drugs Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Generic Drugs Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Generic Drugs Sales Market Share by Type (2018-2023)
- 6.3 Global Generic Drugs Market Size Market Share by Type (2018-2023)
- 6.4 Global Generic Drugs Price by Type (2018-2023)
- 7 Generic Drugs Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Generic Drugs Market Sales by Application (2018-2023)
- 7.3 Global Generic Drugs Market Size (M USD) by Application (2018-2023)
- 7.4 Global Generic Drugs Sales Growth Rate by Application (2018-2023)
- 8 Generic Drugs Market Segmentation by Region
- 8.1 Global Generic Drugs Sales by Region
- 8.1.1 Global Generic Drugs Sales by Region
- 8.1.2 Global Generic Drugs Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Generic Drugs Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Generic Drugs Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Generic Drugs Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Generic Drugs Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Generic Drugs Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Teva
- 9.1.1 Teva Generic Drugs Basic Information
- 9.1.2 Teva Generic Drugs Product Overview
- 9.1.3 Teva Generic Drugs Product Market Performance
- 9.1.4 Teva Business Overview
- 9.1.5 Teva Generic Drugs SWOT Analysis
- 9.1.6 Teva Recent Developments
- 9.2 Novartis - Sandoz
- 9.2.1 Novartis - Sandoz Generic Drugs Basic Information
- 9.2.2 Novartis - Sandoz Generic Drugs Product Overview
- 9.2.3 Novartis - Sandoz Generic Drugs Product Market Performance
- 9.2.4 Novartis - Sandoz Business Overview
- 9.2.5 Novartis - Sandoz Generic Drugs SWOT Analysis
- 9.2.6 Novartis - Sandoz Recent Developments
- 9.3 Mylan
- 9.3.1 Mylan Generic Drugs Basic Information
- 9.3.2 Mylan Generic Drugs Product Overview
- 9.3.3 Mylan Generic Drugs Product Market Performance
- 9.3.4 Mylan Business Overview
- 9.3.5 Mylan Generic Drugs SWOT Analysis
- 9.3.6 Mylan Recent Developments
- 9.4 Sun Pharmaceutical
- 9.4.1 Sun Pharmaceutical Generic Drugs Basic Information
- 9.4.2 Sun Pharmaceutical Generic Drugs Product Overview
- 9.4.3 Sun Pharmaceutical Generic Drugs Product Market Performance
- 9.4.4 Sun Pharmaceutical Business Overview
- 9.4.5 Sun Pharmaceutical Generic Drugs SWOT Analysis
- 9.4.6 Sun Pharmaceutical Recent Developments
- 9.5 Aspen
- 9.5.1 Aspen Generic Drugs Basic Information
- 9.5.2 Aspen Generic Drugs Product Overview
- 9.5.3 Aspen Generic Drugs Product Market Performance
- 9.5.4 Aspen Business Overview
- 9.5.5 Aspen Generic Drugs SWOT Analysis
- 9.5.6 Aspen Recent Developments
- 9.6 Fresenius Kabi
- 9.6.1 Fresenius Kabi Generic Drugs Basic Information
- 9.6.2 Fresenius Kabi Generic Drugs Product Overview
- 9.6.3 Fresenius Kabi Generic Drugs Product Market Performance
- 9.6.4 Fresenius Kabi Business Overview
- 9.6.5 Fresenius Kabi Recent Developments
- 9.7 Pfizer (Hospira)
- 9.7.1 Pfizer (Hospira) Generic Drugs Basic Information
- 9.7.2 Pfizer (Hospira) Generic Drugs Product Overview
- 9.7.3 Pfizer (Hospira) Generic Drugs Product Market Performance
- 9.7.4 Pfizer (Hospira) Business Overview
- 9.7.5 Pfizer (Hospira) Recent Developments
- 9.8 Sanofi
- 9.8.1 Sanofi Generic Drugs Basic Information
- 9.8.2 Sanofi Generic Drugs Product Overview
- 9.8.3 Sanofi Generic Drugs Product Market Performance
- 9.8.4 Sanofi Business Overview
- 9.8.5 Sanofi Recent Developments
- 9.9 Aurobindo
- 9.9.1 Aurobindo Generic Drugs Basic Information
- 9.9.2 Aurobindo Generic Drugs Product Overview
- 9.9.3 Aurobindo Generic Drugs Product Market Performance
- 9.9.4 Aurobindo Business Overview
- 9.9.5 Aurobindo Recent Developments
- 9.10 Lupin
- 9.10.1 Lupin Generic Drugs Basic Information
- 9.10.2 Lupin Generic Drugs Product Overview
- 9.10.3 Lupin Generic Drugs Product Market Performance
- 9.10.4 Lupin Business Overview
- 9.10.5 Lupin Recent Developments
- 9.11 Dr. Reddy's
- 9.11.1 Dr. Reddy's Generic Drugs Basic Information
- 9.11.2 Dr. Reddy's Generic Drugs Product Overview
- 9.11.3 Dr. Reddy's Generic Drugs Product Market Performance
- 9.11.4 Dr. Reddy's Business Overview
- 9.11.5 Dr. Reddy's Recent Developments
- 9.12 Apotex
- 9.12.1 Apotex Generic Drugs Basic Information
- 9.12.2 Apotex Generic Drugs Product Overview
- 9.12.3 Apotex Generic Drugs Product Market Performance
- 9.12.4 Apotex Business Overview
- 9.12.5 Apotex Recent Developments
- 9.13 Cipla
- 9.13.1 Cipla Generic Drugs Basic Information
- 9.13.2 Cipla Generic Drugs Product Overview
- 9.13.3 Cipla Generic Drugs Product Market Performance
- 9.13.4 Cipla Business Overview
- 9.13.5 Cipla Recent Developments
- 9.14 ENDO (Par Pharmaceutical)
- 9.14.1 ENDO (Par Pharmaceutical) Generic Drugs Basic Information
- 9.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Overview
- 9.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product Market Performance
- 9.14.4 ENDO (Par Pharmaceutical) Business Overview
- 9.14.5 ENDO (Par Pharmaceutical) Recent Developments
- 9.15 Stada Arzneimittel
- 9.15.1 Stada Arzneimittel Generic Drugs Basic Information
- 9.15.2 Stada Arzneimittel Generic Drugs Product Overview
- 9.15.3 Stada Arzneimittel Generic Drugs Product Market Performance
- 9.15.4 Stada Arzneimittel Business Overview
- 9.15.5 Stada Arzneimittel Recent Developments
- 9.16 Krka Group
- 9.16.1 Krka Group Generic Drugs Basic Information
- 9.16.2 Krka Group Generic Drugs Product Overview
- 9.16.3 Krka Group Generic Drugs Product Market Performance
- 9.16.4 Krka Group Business Overview
- 9.16.5 Krka Group Recent Developments
- 9.17 Nichi-Iko Pharmaceutical
- 9.17.1 Nichi-Iko Pharmaceutical Generic Drugs Basic Information
- 9.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Overview
- 9.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product Market Performance
- 9.17.4 Nichi-Iko Pharmaceutical Business Overview
- 9.17.5 Nichi-Iko Pharmaceutical Recent Developments
- 9.18 Valeant
- 9.18.1 Valeant Generic Drugs Basic Information
- 9.18.2 Valeant Generic Drugs Product Overview
- 9.18.3 Valeant Generic Drugs Product Market Performance
- 9.18.4 Valeant Business Overview
- 9.18.5 Valeant Recent Developments
- 9.19 Zydus Cadila
- 9.19.1 Zydus Cadila Generic Drugs Basic Information
- 9.19.2 Zydus Cadila Generic Drugs Product Overview
- 9.19.3 Zydus Cadila Generic Drugs Product Market Performance
- 9.19.4 Zydus Cadila Business Overview
- 9.19.5 Zydus Cadila Recent Developments
- 9.20 Hikma
- 9.20.1 Hikma Generic Drugs Basic Information
- 9.20.2 Hikma Generic Drugs Product Overview
- 9.20.3 Hikma Generic Drugs Product Market Performance
- 9.20.4 Hikma Business Overview
- 9.20.5 Hikma Recent Developments
- 9.21 Pharmaniaga Berhad
- 9.21.1 Pharmaniaga Berhad Generic Drugs Basic Information
- 9.21.2 Pharmaniaga Berhad Generic Drugs Product Overview
- 9.21.3 Pharmaniaga Berhad Generic Drugs Product Market Performance
- 9.21.4 Pharmaniaga Berhad Business Overview
- 9.21.5 Pharmaniaga Berhad Recent Developments
- 9.22 Hovid Berhad
- 9.22.1 Hovid Berhad Generic Drugs Basic Information
- 9.22.2 Hovid Berhad Generic Drugs Product Overview
- 9.22.3 Hovid Berhad Generic Drugs Product Market Performance
- 9.22.4 Hovid Berhad Business Overview
- 9.22.5 Hovid Berhad Recent Developments
- 9.23 Duopharma Biotech
- 9.23.1 Duopharma Biotech Generic Drugs Basic Information
- 9.23.2 Duopharma Biotech Generic Drugs Product Overview
- 9.23.3 Duopharma Biotech Generic Drugs Product Market Performance
- 9.23.4 Duopharma Biotech Business Overview
- 9.23.5 Duopharma Biotech Recent Developments
- 9.24 Kotra Pharma
- 9.24.1 Kotra Pharma Generic Drugs Basic Information
- 9.24.2 Kotra Pharma Generic Drugs Product Overview
- 9.24.3 Kotra Pharma Generic Drugs Product Market Performance
- 9.24.4 Kotra Pharma Business Overview
- 9.24.5 Kotra Pharma Recent Developments
- 9.25 HOE Pharmaceutical
- 9.25.1 HOE Pharmaceutical Generic Drugs Basic Information
- 9.25.2 HOE Pharmaceutical Generic Drugs Product Overview
- 9.25.3 HOE Pharmaceutical Generic Drugs Product Market Performance
- 9.25.4 HOE Pharmaceutical Business Overview
- 9.25.5 HOE Pharmaceutical Recent Developments
- 9.26 Y.S.P. Industries
- 9.26.1 Y.S.P. Industries Generic Drugs Basic Information
- 9.26.2 Y.S.P. Industries Generic Drugs Product Overview
- 9.26.3 Y.S.P. Industries Generic Drugs Product Market Performance
- 9.26.4 Y.S.P. Industries Business Overview
- 9.26.5 Y.S.P. Industries Recent Developments
- 10 Generic Drugs Market Forecast by Region
- 10.1 Global Generic Drugs Market Size Forecast
- 10.2 Global Generic Drugs Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Generic Drugs Market Size Forecast by Country
- 10.2.3 Asia Pacific Generic Drugs Market Size Forecast by Region
- 10.2.4 South America Generic Drugs Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Generic Drugs by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Generic Drugs Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Generic Drugs by Type (2024-2029)
- 11.1.2 Global Generic Drugs Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Generic Drugs by Type (2024-2029)
- 11.2 Global Generic Drugs Market Forecast by Application (2024-2029)
- 11.2.1 Global Generic Drugs Sales (K MT) Forecast by Application
- 11.2.2 Global Generic Drugs Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook